Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... renal insufficiency of any severity due to hepato-renal syndrome or in the perioperative liver transplant period. The Company is implementing this label change in all ... however, has been asserted between the use of GBCAs and nephrogenic systemic fibrosis (NSF) among patients with severe renal impairment. This subset of patients can be easily ...
2009 NOV 23 ... to investigate the effect of administering praziquantel (PZQ), focusing on the liver stereological findings of malnourished mice infected with Schistosoma mansoni. Thirty ... of daily administration for 5 days. Volume density (hepatocytes, sinusoids and hepatic fibrosis) was determined by stereology using a light microscope. Body weight gain and total serum ...
2009 NOV 23 ... the risk of developing cirrhosis and its complications, namely hepatocellular carcinoma, liver decompensation, hepatic encefalopathy and espohageal variceal bleeding," investigators ... prevalence of 1.6-2%. The prognosis of chronic hepatitis C depends on the rate of fibrosis progression which, over a 20-30-year time span, may determine the risk of developing ...
2009 NOV 23 ... thoracic duct in certain diseases suspected to involve an abnormal load of chyle (liver, heart, and inflammatory bowel diseases). The study was approved by the institutional ... Chronic Hepatitis, Gastroenterology, Infectious Disease, Liver Cirrhosis, Hepatology, Fibrosis, Inflammatory Bowel Disease, Radiology, University Hospital. This article ...
2009 NOV 23 ... a study "To evaluate the usefulness of a non-invasive clinical score to predict liver fibrosis in the steatosis associated with morbid obesity. we included 88 patients, who underwent ...
2009 NOV 20 ... "Nonalcoholic fatty liver disease (NAFLD) may have distinct histological features in children and adults, but to ... or adult versus type 2 or pediatric nonalcoholic steatohepatitis [NASH]) were recorded. Fibrosis was staged using a published 7-point scale. The median age was 12 years (range, 4-18 ...
2009 NOV 23 ... carcinoma (HCC)." "This study explored premalignant changes in the liver tissue content of collagen (as hydroxyproline, HP), total glycosaminoglycans (TGAGs), ... This might be stimulated by up-regulation of free cathepsin D activity. Perhaps tissue fibrosis is not a condition for developing HCC because collagen was significantly depressed. ...
2009 NOV 23 ... States, Biliary Cirrhosis, Diagnostics, Fibrosis, Gastroenterology, Hepatology, Liver Cirrhosis, Rheumatology, Sclerosis, University of Texas. This article was ...
2009 NOV 23 ... "Blood hyaluronic acid (HA) concentration was measured in dogs with various liver diseases to determine its relationship with histological fibrosis of the liver. The ...
2009 NOV 23 ... According to a study from Taipei, Taiwan, "The Model for End-Stage Liver Disease (MELD) score is currently used as a disease severity index of cirrhotic patients ... City:Taipei, Country:Taiwan, Bioengineering, Biomedical Engineering, Biomedicine, Fibrosis, Gastroenterology, Hepatic Resection, Hepatocellular Cancer, Hepatocellular Carcinoma, ...
2009 NOV 23 ... operations, 18 in 18 patients with documented cirrhosis and 25 in 24 patients after liver transplantation (LT), over a 10-year period at UCLA. Average follow up was 33 months." ... Country:United States, Bioengineering, Biomedical Engineering, Biomedicine, Cirrhosis, Fibrosis, Gastroenterology, Hernia, Herniorrhaphy, Inguinal Hernia, Liver Transplant, Organ ...
2009 NOV 23 ... with HCC detected by ultrasound imaging over 8 years and staged by the Barcelona Clinic Liver Cancer (BCLC) criteria, we identified 7 cases (1.7%) with HCC occurring in the setting ... but 1 patient had well-differentiated HCC in the setting of NASH without cirrhosis (fibrosis stage 1) based on repeated liver biopsies, the absence of portal hypertension by ...
2009 NOV 23 ... journal Clinical Microbiology and Infection report. "Similar to nonviral liver diseases, HBV and HCV infection can cause chronic injury to the liver, with subsequent ... infection can cause chronic injury to the liver, with subsequent progression to severe fibrosis and cirrhosis. The presence of cirrhosis is a major risk factor for the development of ...
2009 NOV 23 ... genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Tropical Medicine & International Health, 2009;14(11):1418-1425). For ...
2009 NOV 16 ... A new study, 'Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells,' is now available. ...
2009 NOV 16 ... "Liver biopsy remains the gold standard for diagnosing nonalcoholic steatohepatitis (NASH). We ... 194 [151, 270], 200 [148, 284], respectively, P< 0.001). Moreover, the odds of having fibrosis on liver biopsy increased with increasing plasma CK-18 fragment levels (P < 0.001). ...
2009 NOV 16 ... treatment of chronic hepatitis C in patients 3 years of age and older with compensated liver disease. The following points should be considered when initiating therapy ... previous nonresponse, previous pegylated interferon treatment, significant bridging fibrosis or cirrhosis, and genotype 1 infection. (3) No safety and efficacy data are available ...
2009 NOV 16 ... who had NASH but not diabetes, pioglitazone improved key histological features and liver enzymes; however, vitamin E was more successful for the treatment of NASH in these ... primary endpoint, which was a predetermined histological improvement and no worsening of fibrosis. According to the study's author, Arun Sanyal, MD, of the Virginia ...
